Archives
-
Cdk1–PP2A Switch Controls Atypical E2F Degradation
2026-08-12
This preprint identifies a phosphorylation-dependent molecular switch that couples Cdk1, PP2A, and APC/C activity to the orderly degradation of E2F7 and E2F8 during mitotic exit. By combining cell-based and cell-free systems, the study shows how dephosphorylation in G1 helps release E2F1-driven transcriptional activity and clarifies how phosphorylation can regulate the timing of ubiquitin-mediated substrate destruction.
-
CTCF–FLG-AS1 Control of PDAC Progression
2026-08-12
This study identifies a multilayered mechanism in which CTCF drives pancreatic ductal adenocarcinoma through FLG-AS1-dependent chromatin regulation, IGF2BP2 activity, CSF1 signaling, and macrophage polarization. Its main significance is the connection of tumor-intrinsic epigenetic and RNA-regulatory events with a tumor-associated macrophage response, providing a mechanistic framework for preclinical immunotherapy research.
-
BKT140 CXCR4 Antagonist Workflow Guide
2026-08-11
A scenario-based guide to using BKT140 (BL-8040, TF 14016) CXCR4 Antagonist, SKU B7833, in viability, chemotaxis, apoptosis, and hematopoietic stem cell mobilization assays. It connects CXCR4 biology with practical controls, formulation choices, interpretation safeguards, and vendor-selection criteria.
-
Fenofibrate, Aging, and PPARα-YAP Liver Growth
2026-08-11
The reference study shows that Fenofibrate induces comparable liver enlargement and PPARα-YAP pathway activation in adult and aging mice. By combining chemically induced, naturally aged, and senescence-accelerated models, it suggests that aging does not substantially blunt the hepatic hypertrophic or proliferative response to this PPARα agonist.
-
SHH, FGF10, and Species-Specific Penile Development
2026-08-10
A 2025 comparative study shows that differences in Shh, Fgf10, and Fgfr2 expression help explain why mice form a tubular urethra without a prominent open groove, whereas guinea pigs form a transiently open urethral groove and develop the prepuce later. By combining developmental expression mapping with ex vivo pathway perturbation, the study connects species-specific gene regulation to penile morphogenesis and provides a more appropriate framework for interpreting human developmental biology.
-
S. eriocheiris Entry into Drosophila S2 Cells
2026-08-09
Wei et al. established a Drosophila Schneider 2 cell model showing that Spiroplasma eriocheiris invades host cells through clathrin-mediated endocytosis and macropinocytosis. Pharmacological inhibition, cytoskeletal disruption, and cellular injury analyses provide a useful framework for studying intracellular infection by a crustacean pathogen in an invertebrate-derived system.
-
ACE2, Diminazene Aceturate, and Septic Cardiomyopathy
2026-08-08
The February 2024 reference study identifies ACE2 downregulation as a feature of sepsis-induced cardiomyopathy and links pharmacological ACE2 activation with MasR–Sirt1-regulated mitochondrial biogenesis. Using complementary mouse, histological, molecular, and functional assays, the work provides a mechanistic framework for interpreting mitochondrial dysfunction in septic cardiac injury while highlighting the limits of pharmacological evidence.
-
Metformin, EDH, and Mesenteric Perfusion in Colitis
2026-08-07
A 2025 European Journal of Pharmacology study identifies a direct vascular action of metformin in mesenteric resistance vessels, linking endothelial calcium signaling and endothelium-dependent hyperpolarization to protection of the colonic mucosa in murine colitis. Its combination of human and mouse arteriole studies, endothelial-cell electrophysiology, TRPV4 genetics, and a DSS disease model provides a mechanistic framework for evaluating metformin as a potential colitis therapy, while leaving clinical translation unresolved.
-
Vagal Heart-Brain Axis in PTSD: Insights from Isoproterenol
2026-08-07
This study delineates a mechanistic heart-brain pathway in PTSD, showing that vagal-mediated transmission of sympathetic cardiac signals drives insular cortex hyperactivity and behavioral pathology in mice. Chronic isoproterenol administration robustly models these features, and findings clarify both cardiac and neural contributions to PTSD, refining preclinical research strategies.
-
Norovirus Hijacks NINJ1 for Selective Protein Secretion
2026-08-06
Song et al. uncover how murine norovirus (MNoV) strategically co-opts the host protein NINJ1 to enable selective secretion of its NS1 protein during infection, revealing a new paradigm for unconventional protein export via regulated cell death. These findings have broad implications for understanding virus-host interactions, cell death regulation, and selective cargo release.
-
MEK1/2-ERK1/2 Pathway Drives Lung Hemorrhage in Murine Lupus
2026-08-06
This study reveals that MEK1/2-ERK1/2 signaling underlies lung endothelial injury and hemostatic disruption in murine lupus, promoting diffuse alveolar hemorrhage (DAH). Pharmacological inhibition with Trametinib (GSK1120212) or ERK1/2 inhibitors prevented DAH, highlighting the pathway's central role and suggesting new targets for experimental intervention in SLE-related lung disease.
-
Dissecting Chuanxiong Cortex and Pith Mechanisms for Coronar
2026-08-05
This study pioneers the comparative analysis of Ligusticum chuanxiong rhizome cortex (RC) and rhizome pith (RP) in coronary heart disease (CHD) intervention by integrating advanced SPME-GC×GC-MS metabolomics with network pharmacology. The findings elucidate distinct volatile profiles and molecular targets for RC and RP, informing the optimization of traditional medicinal formulations and targeted therapeutic strategies for cardiovascular disease.
-
Dual-Action p38α MAPK Inhibitors: Mechanistic Insights and I
2026-08-05
The reference study reveals that certain p38α MAP kinase inhibitors not only block kinase activity but also accelerate dephosphorylation by phosphatases through a shared conformational mechanism. This dual-action effect offers new strategies for improving specificity and potency in kinase inhibitor design, with important implications for inflammation and apoptosis research.
-
Neuromedin S (rat): Technical Parameters and Workflow Guidan
2026-08-04
Neuromedin S (rat) provides a chemically defined, endogenous neuromedin U receptor agonist for controlled activation of GPCR/G protein signaling in rat-based research. It addresses the need for standardized ligand controls in pathways like energy homeostasis regulation and stress response. This product is not suitable for diagnostic, therapeutic, or cross-species applications.
-
SEMA3E Drives Beige Adipocyte Differentiation via β-Catenin
2026-08-04
This study identifies SEMA3E as a pivotal regulator of beige adipocyte differentiation and thermogenesis in mice, acting through β-catenin signaling. The findings offer mechanistic insight into adipose tissue plasticity and highlight new molecular targets for metabolic disease research.